Ray-Coquard I - Search Results

1

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.

Borg C, Ray-Coquard I, Philip I, Clapisson G, Bendriss-Vermare N, Menetrier-Caux C, Sebban C, Biron P, Blay JY. Borg C, et al. Cancer. 2004 Dec 1;101(11):2675-80. doi: 10.1002/cncr.20688. Cancer. 2004. PMID: 15503313 Free article.

2

[Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].

Ray-Coquard I, Blay JY. Ray-Coquard I, et al. Bull Cancer. 2002 Jun;89(6):567-9. Bull Cancer. 2002. PMID: 12135855 Free article. French. No abstract available.

3

[Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].

Bachelot T, Ray-Coquard I, Coeffic D, Barletta H, Gouttebel MC, Mayer B, Muron T, Laroche GD, Vincent M, Farsi F, Philip T. Bachelot T, et al. Bull Cancer. 2002 Oct;89(10):897-903. Bull Cancer. 2002. PMID: 12441282 Free article. Review. French.

4

[Gastro-intestinal stromal tumors: news and comments].

Ray-Coquard I, Le Cesne A, Michallet V, Boukovinas I, Ranchere D, Thiesse P, Baty V, Blay JY. Ray-Coquard I, et al. Bull Cancer. 2003 Jan;90(1):69-76. Bull Cancer. 2003. PMID: 12609807 Free article. Review. French.

5

Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimens.

Ray-Coquard I, Bachelot T, Guastalla JP, Levy E, Tigaud JD, Vincent P, Dramais D, Assouline D, Pujade-Lauraine E. Ray-Coquard I, et al. Gynecol Oncol. 2003 Mar;88(3):351-7. doi: 10.1016/s0090-8258(02)00151-8. Gynecol Oncol. 2003. PMID: 12648586 Clinical Trial.

6

[Anemia and chemotherapy].

Ray-Coquard I, Bachelot T, Sebban C, Biron P, Guastalla JP, Blay JY. Ray-Coquard I, et al. Bull Cancer. 2003 Apr;90 Spec No:S133-43. Bull Cancer. 2003. PMID: 12856425 Free article. Review. French.

7

Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients.

Marec-Berard P, Blay JY, Schell M, Buclon M, Demaret C, Ray-Coquard I. Marec-Berard P, et al. J Clin Oncol. 2003 Nov 15;21(22):4235-8. doi: 10.1200/JCO.2003.09.121. J Clin Oncol. 2003. PMID: 14615453

8

[Docetaxel and ovarian cancer].

Ray-Coquard I. Ray-Coquard I. Bull Cancer. 2004 Feb;91(2):159-65. Bull Cancer. 2004. PMID: 15047455 Free article. Review. French.

9

Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas.

Blay JY, Ray-Coquard I, Alberti L, Ranchère D. Blay JY, et al. Cancer Treat Res. 2004;120:151-67. doi: 10.1007/1-4020-7856-0_9. Cancer Treat Res. 2004. PMID: 15217223 Review. No abstract available.

10

[Organization and impact of the multidisciplinary committee in oncology].

Castel P, Blay JY, Meeus P, Sunyach MP, Ranchère-Vince D, Thiesse P, Bergeron C, Marec-Bérard P, Lurkin A, Ray-Coquard I. Castel P, et al. Bull Cancer. 2004 Oct;91(10):799-804. Bull Cancer. 2004. PMID: 15556881 Free article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters